DOTmed December 20, 2023
John R. Fischer

Apple has suspended sales for two of its Apple Watches designed with a blood oxygen sensor that is the center of an intellectual property dispute with Masimo.

The company announced on December 19 that it would cease sales for Series 9 and Ultra 2 versions of its watch for online customers on December 21 and in stores on December 24 in compliance with a ban by the International Trade Commission on watches with the pulse-based oximetry capabilities. It will continue to sell its Apple Watch SE, which lacks the light-based pulse oximetry feature, according to the Associated Press.

The ITC proposed the ban in October following a review of the case. In it, Masimo says that the blood oxygen feature...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article